Introduction
Transmission via the sexual mucosa is the main route of human immunodeficiency virus-1 (HIV-1) infection worldwide. 1 the SIV-infected macaque model, 5, 6 or ex vivo, in vaginal epithelial explants. 3 In vitro,
immature DCs replicate CCR5 (R5)-tropic viruses, albeit less efficiently than primary CD4 Tlymphocytes. [7] [8] [9] Furthermore, interactions between DCs and HIV-1 have highlighted their important role in HIV-1 transmission. The efficient transfer of HIV-1 from DCs to CD4 Tlymphocytes, first described in 1992, 10 may largely contribute to HIV-1 propagation and dissemination through the body, [10] [11] [12] [13] [14] [15] [16] but the precise mechanisms leading to HIV-1 transfer remain unclear. 17, 18 DCs bind native free viral particles, but viruses are rarely colocalized with endolysosomal markers, suggesting that viral infection may alter endolysosomal trafficking. 19 Two modes of HIV-1 transfer have been well described: trans-infection and cisinfection. 19, 20 Infectious viral particles in the intracellular compartments of DCs can be rapidly redirected to virological synapses formed at the site of contact between infected DCs and CD4
T-lymphocytes. 11, [19] [20] [21] [22] This trans-infection may also be mediated by DCs-derived exosomes released from immature monocyte-derived dendritic cells (MoDCs). 23 In addition, HIV-1 bound to C-type lectins, such as DC-SIGN, on the surface of immature DCs, can be efficiently captured and transferred directly to CD4 T-lymphocytes during cell-to-cell
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From contact. 12, 17, 24, 25 This HIV-1 transfer, also referred to as trans-infection, occurs in the absence of viral replication in DCs. 12 This trans-infection of CD4 T-lymphocytes is transient, as HIV-1 transfer decays within 24 hours 19 after the addition of CD4 T-lymphocytes to infected DCs. 26 A second transfer phase is then detected in immature DCs, after 48 hours, as an AZTsensitive increase in proviral DNA levels. 19 This second type of transfer, in cis, occurs over a longer period, after conventional HIV-1 fusion and de novo virus production in immature DCs. 19 The mechanism of viral transfer from DCs to CD4 T-lymphocytes can therefore be addressed as a function of time: the addition of CD4 T-lymphocytes to DCs just after their exposure to HIV-1 may allow the analysis of HIV-1 transfer in trans, whereas the addition of CD4 T-lymphocytes one day after DC infection is likely to promote transfer in cis.
It has been suggested that the transfer of viral particles from MoDCs to CD4 Tlymphocytes is resistant to neutralizing antibodies (NAbs). 8, 25 The authors of these studies suggested that the virological synapse between infected DCs and CD4 T-lymphocytes impeded the binding of NAbs to the transferred virus. 8 By contrast, other studies have reported HIV-1 transfer to be sensitive to NAbs. 18, 27, 28 We previously showed that HIV-1-exposed immature MoDCs produce large numbers of new viral particles when cocultured with primary CD4 T-lymphocytes. 26 The HIV-1 particles produced by DCs and released into the supernatant may interfere with the antibody (Ab)-mediated inhibition of HIV-1 transfer to T cells, as antibodies (Abs) can inhibit HIV-1 transfer to T cells but not HIV-1 production in
DCs. This would result in the release of HIV-1 into the supernatant, despite the efficient inhibition of HIV-1 transfer to CD4 T-lymphocytes. We therefore analyzed the intracellular p24 of HIV-1 produced in DCs and in CD4 T-lymphocytes directly, rather than assessing HIV-1 release into the supernatant, to make it possible to distinguish between the virus produced by DCs and that transferred to CD4 T-lymphocytes. We found that the addition of NAbs to HIV-1-loaded DCs at the same time as CD4 T-lymphocytes strongly inhibited the 3) was obtained from BEI Resources, NIAID, NIH. Endotoxin levels in the anti-HIV-1-specific Abs preparations were determined by using a commercially Limulus Amebocyte Lysate (LAL) chromogenic endotoxin quantitation kit (Pierce®, Thermo Scientific).
Cell preparation
All human blood samples were collected from donors seronegative for HIV-1 and HCV (EFS, Strasbourg). Immature monocyte-derived dendritic cells (MoDCs) were obtained by the differentiation of purified human blood CD14 + monocytes, with immunomagnetic bead isolation, after Ficoll-Hypaque sedimentation (AutoMACS; Miltenyi Biotec). As previously described, 26, 29, 30 autologous CD4 T-lymphocytes were purified by positive selection, after CD14 purification. Primary purified CD4 T-lymphocytes were activated by incubation with
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Virus preparation
Primary HIV-1 isolates were amplified on human blood leukocytes, as previously described. 29 Virus stocks collected at peak virus production were concentrated 70-fold with a 100-kDa cutoff polyethersulfone filter (Centricon Plus-70 Biomax Filter, Millipore, Molsheim, France).
Primary R5 HIV-1 BaL (subtype B) was provided by S. Gartner, M. Popovic and R. Gallo from the National Institutes of Health (NIH). HIV-1 TV1 (subtype C, R5 strain) was obtained from S.
Engelbrecht. HIV-1 QH0 (subtype B, R5 strain) was obtained from the National Institute for Biological Standards and Control (NIBSC).
HIV-1 transfer experiments
The conditions used for MoDCs infection and coculture with PHA-activated autologous CD4
T-lymphocytes were similar to those previously used. 26 Briefly, immature MoDCs were infected with primary R5 HIV-1 at a concentration of 500 ng/mL viral p24 antigen. After two hours of incubation, the cells were thoroughly washed to remove unbound free viral particles. 
Antibody neutralizing activity on purified CD4 T-lymphocytes
The neutralizing activity of Abs was assessed as previously described. 32 which generated a graphical output.
Antibody-binding detection assay
Cells were incubated with various anti-HIV-1-specific Abs (at a concentration of 100 µg/mL, except for VRC01 and VRC03, used at a concentration of 50 µg/mL) for 10 min at 4°C, 
Enzyme-linked immunosorbent assay
We determined the amount of HIV-1 p24 antigen released into the supernatant of cocultured cell populations by enzyme-linked immunosorbent assay (ELISA) (Innogenetics/Ingen). 
Statistical analysis
Results
Productive HIV-1 infection of MoDCs and CD4 T-lymphocytes
We 
Kinetics of HIV-1 fusion and replication
We analyzed the kinetics of HIV-1 membrane fusion in coculture conditions, by adding a fusion inhibitor (T20) at various time points post-infection ( Figure 3A ). When T20 was added to HIV-1-loaded MoDCs at the same time as CD4 T-lymphocytes, about 20% of the MoDCs were found positive for intracellular p24 antigen 48 hours later compared to control MoDCs in the absence of T20. Thus, about 80% of the HIV-1 particles had yet to fuse with immature MoDCs after two hours of incubation ( Figure 3A ) and were still accessible to HIV-1-specific Abs. Moreover, at this time point, T20 almost completely inhibited HIV-1 transfer to primary CD4 T-lymphocytes, demonstrating the requirement for fusion in HIV-1 transfer to CD4 Tlymphocytes, as previously described ( Figure 3A) . 33, 34 We investigated the kinetics of HIV- 
Single cycle of HIV-1 infection in MoDCs and CD4 T-lymphocytes in coculture
We investigated whether the HIV-1 replication in MoDCs and CD4 T-lymphocytes corresponded to a single cycle of HIV-1 infection after 48 hours of incubation, by adding a protease inhibitor, indinavir (IDV). IDV prevent new cycles of infection by blocking final assembly and maturation of newly synthesized virions. In the presence of IDV, infected
MoDCs correspond to 80% of control infected MoDCs (in the absence of IDV) ( Figure 3C ).
The HIV-1 replication detected in these cells after 48 hours was therefore due essentially to a We also analyzed viral release into the supernatant. Similar curves were obtained for the inhibition of HIV-1 transfer and the inhibition of p24 release into the supernatant, thus, confirming that overall productive infection was inhibited by NAbs ( Figure 4A-D) . The 
IgG-mediated inhibition of HIV-1 replication in MoDCs is correlated with the maturation status of these cells
DC maturation decreases susceptibility to HIV-1 R5 infection. 36 We therefore assessed the capacity of Abs to induce MoDC maturation. The expression of the DC maturation marker CD83 on the surface of infected MoDCs was determined in the coculture, with various concentrations of Abs, and compared to MoDC maturation in the absence of Abs (Table 1 and Figure 7A ). The anti-gp41 NAbs 4E10 and 2F5 induced a high percentage of mature MoDCs (50% and 42%, respectively, Table 1 and Figure 7A ). DC maturation was slightly lower in the presence of b12 and no CD83 expression was detected with 2G12, even when present at a concentration of 100 µg/mL ( Table 1 ). The NNAbs 246-D and 5F3 induced MoDC maturation, whereas 4B3 and 1570-D did not increase the level of CD83 expression on DCs (Table 1) . This maturation could not be due to the presence of endotoxins as endotoxin levels were found to be very low (between 0.0003 and 0.196 EU) at 100 µg/mL of Abs, the highest concentration used. In addition, DC maturation was inversely correlated with the relative 
Binding of antibodies to FcγRs on the surface of MoDCs
We have previously demonstrated the involvement of Fcγ receptors (FcγRs) in the mechanism of HIV-1 inhibition by NAbs and NNAbs in MoDCs. 29, 30 We investigated the mechanism of MoDCs. We therefore used these conditions to assess the capacity of HIV-1-specific Abs to inhibit HIV-1 transfer in trans to CD4 T-lymphocytes. We demonstrated that NAbs efficiently inhibited this transfer; the cell-to-cell spread of HIV is therefore susceptible to the inhibitory properties of Abs. An interesting trend was observed for 2G12, which inhibited HIV-1 cell-tocell transmission slightly more efficiently than it neutralized cell-free virus. Indeed, 2G12
recognizes glycans with high mannose content on the surface of the viral envelope gp120. 37 These glycans are also recognized by DC-SIGN and thus 2G12 interferes with the viral envelope gp120/DC-SIGN interaction. 37 As DC-SIGN is thought to play a critical role in HIV transfer, 24 2G12 may have an additional effect, by blocking DC-SIGN/CD4 interaction.
Fluorescence microscopy and electron tomography have shown that inhibitors have access to the preformed virological synapses and can interfere with HIV-1 cell-to-cell infection. 34 Consequently, the HIV-1 bound to the DC surface remains accessible to neutralizing monoclonal Abs. Moreover, the inhibitory effects of NAbs on HIV-1 transfer were of similar strength to those detected when free HIV-1 particles infect CD4 T-lymphocytes (Supplemental Figure S2 ) or in more classical neutralization assays involving PBMCs. 29, 30 In neutralizing conditions, PBMCs were first incubated with free virus particles, and then cultured to confluence. HIV-1 transfer from cell-to-cell probably occurs during this incubation phase, and Abs would also need to inhibit this cell-to-cell transmission. This may therefore account for the lower overall inhibitory activity of NAbs in conventional primary
PBMCs assays than in a single cycle T cell line based neutralization assay. For
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In the context of DCs-T cells cross-talk, HIV/Abs immune complexes have been shown to be more efficient than virus alone for triggering antigen presentation by DCs. 45 FcγR engagement on DCs induces maturation. 45 We therefore assessed the capacity of Ab to bind receptors on the surface of DCs. We found that some Abs, such as the NAbs 4E10 and 2F5 in particular, efficiently bound to MoDCs. This binding partially involved FcγRs, as lower levels of Ab binding were observed in the presence of anti-FcγR Abs. However, some FcγR-unrelated binding was also observed. This additional binding capacity of the NAbs 4E10 and 2F5 may be due to their polyspecific autoantibody properties, 46 as they bind other proteins, such as phospholipids. For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From
